Myanmar Oxford Clinical Research Unit Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Myanmar (2013)

Organization Overview

First Clinical Trial
2013
NCT01872702
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Myanmar Oxford Clinical Research Unit

Active Ingredients

Drugs in Phase 3 Trials (2)

coartem (1 trial)

lumefantrine (Coartem) (1 trial)

Drugs in Phase 2 Trials (1)

viper antivenom (1 trial)

Drugs in Other Trials (3)

dihydroartemisinin (1 trial)

piperaquine (1 trial)

primaquine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Malaria (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 6